Histocompatibility Leukocyte Antigen‐A2‐restricted and Tumor‐specific Cytotoxic T Lymphocytes from Tumor‐infiltrating Lymphocytes of a Patient with Testicular Embryonal Cancer...

por Suekane, Shigetaka, Nakao, Masanobu, Inoue, Michiro, Noda, Shinshi, Itoh, Kyogo
Publicado 1997

Immune responses of patients without cancer recurrence after a cancer vaccine over a long term

por Suekane, Shigetaka, Yutani, Shigeru, Toh, Uhi, Yoshiyama, Koichi, Itoh, Kyogo
Publicado 2022

Synchronous primary triple urogenital malignant tumors of kidney, prostate and bladder

por Kurose, Hirofumi, Ueda, Kosuke, Nakiri, Makoto, Matsuo, Mitsunori, Suekane, Shigetaka, Igawa, Tsukasa
Publicado 2020

A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling time

por Noguchi, Masanori, Moriya, Fukuko, Suekane, Shigetaka, Ohnishi, Rei, Matsueda, Satoko, Sasada, Tetsuro, Yamada, Akira, Itoh, Kyogo
Publicado 2013

A useful treatment for patients with advanced mixed-type small cell neuroendocrine carcinoma of the prostate: A case report

por UEMURA, KEI-ICHIRO, NAKAGAWA, GO, CHIKUI, KATSUAKI, MORIYA, FUKUKO, NAKIRI, MAKOTO, HAYASHI, TOKUMASA, SUEKANE, SHIGETAKA, MATSUOKA, KEI
Publicado 2013

Long-term response of over ten years with sorafenib monotherapy in metastatic renal cell carcinoma: a case report

por Ueda, Kosuke, Suekane, Shigetaka, Ogasawara, Naoyuki, Chikui, Katsuaki, Suyama, Shunsuke, Nakiri, Makoto, Nishihara, Kiyoaki, Matsuo, Mitsunori, Igawa, Tsukasa
Publicado 2016

Survival analysis of multiple peptide vaccination for the selection of correlated peptides in urological cancers

por Noguchi, Masanori, Koga, Noriko, Moriya, Fukuko, Suekane, Shigetaka, Yutani, Shigeru, Yamada, Akira, Shichijo, Shigeki, Kakuma, Tatuyuki, Itoh, Kyogo
Publicado 2018

Aldehyde Dehydrogenase 1 Identifies Cells with Cancer Stem Cell-Like Properties in a Human Renal Cell Carcinoma Cell Line

por Ueda, Kosuke, Ogasawara, Sachiko, Akiba, Jun, Nakayama, Masamichi, Todoroki, Keita, Ueda, Keiko, Sanada, Sakiko, Suekane, Shigetaka, Noguchi, Masanori, Matsuoka, Kei, Yano, Hirohisa
Publicado 2013

A Laparoscopic Management Combined with a Flexible Ureteroscope for Ureteral Polyps of More Than 3 cm Length

por Matsuo, Mitsunori, Ueda, Kousuke, Nishihara, Kiyoaki, Nakiri, Makoto, Suyama, Shunsuke, Chikui, Katsuaki, Hayashi, Shuichiro, Kurose, Hirofumi, Ogasawara, Naoyuki, Suekane, Shigetaka, Igawa, Tsukasa
Publicado 2016

Personalized peptide vaccination as second‐line treatment for metastatic upper tract urothelial carcinoma

por Suekane, Shigetaka, Ueda, Kousuke, Nishihara, Kiyoaki, Sasada, Tetsuro, Yamashita, Takuto, Koga, Noriko, Yutani, Shigeru, Shichijo, Shigeki, Itoh, Kyogo, Igawa, Tsukasa, Noguchi, Masanori
Publicado 2017

Remarkable antitumor effect of nivolumab in a patient with metastatic renal cell carcinoma previously treated with a peptide‐based vaccine

por Kurahashi, Ryoma, Motoshima, Takanobu, Fukushima, Yumi, Murakami, Yoji, Yatsuda, Junji, Yamaguchi, Takahiro, Sugiyama, Yutaka, Fukushima, Satoshi, Komohara, Yoshihiro, Suekane, Shigetaka, Kamba, Tomomi
Publicado 2020

Impact of Gleason score of the tumor at the positive surgical margin as a prognostic factor

por Kurose, Hirofumi, Ueda, Kosuke, Ogasawara, Naoyuki, Chikui, Katsuaki, Nakiri, Makoto, Nishihara, Kiyoaki, Matsuo, Mitsunori, Suekane, Shigetaka, Kusano, Hironori, Akiba, Jun, Yano, Hirohisa, Igawa, Tsukasa
Publicado 2022

Prognostic Value of Absolute Lymphocyte Count in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab plus Ipilimumab

por Ueda, Kosuke, Ogasawara, Naoyuki, Ito, Naoki, Ohnishi, Satoshi, Suekane, Hiroki, Kurose, Hirofumi, Hiroshige, Tasuku, Chikui, Katsuaki, Uemura, Keiichiro, Nishihara, Kiyoaki, Nakiri, Makoto, Suekane, Shigetaka, Igawa, Tsukasa
Publicado 2023

Paraganglioma of the urinary bladder: Case report and literature review

por Kurose, Hirofumi, Ueda, Kosuke, Uegaki, Mami, Ogasawara, Naoyuki, Kumagae, Hisaji, Chikui, Katsuaki, Nakiri, Makoto, Nishihara, Kiyoaki, Matsuo, Mitsunori, Suekane, Shigetaka, Akiba, Jun, Yano, Hirohisa, Igawa, Tsukasa
Publicado 2020

Immunological evaluation of peptide vaccination for cancer patients with the HLA-A26 allele

por Sakamoto, Shinjiro, Matsueda, Satoko, Takamori, Shinzo, Toh, Uhi, Noguchi, Masanori, Yutani, Shigeru, Yamada, Akira, Shichijo, Shigeki, Yamada, Teppei, Suekane, Shigetaka, Kawano, Kouichiro, Sasada, Tetsuro, Hattori, Noboru, Kohno, Nobuoki, Itoh, Kyogo
Publicado 2015

Immunological evaluation of peptide vaccination for cancer patients with the HLA ‐A11(+) or ‐A33(+) allele

por Sakamoto, Shinjiro, Matsueda, Satoko, Takamori, Shinzo, Toh, Uhi, Noguchi, Masanori, Yutani, Shigeru, Yamada, Akira, Shichijo, Shigeki, Yamada, Teppei, Suekane, Shigetaka, Kawano, Kouichiro, Naitou, Masayasu, Sasada, Tetsuro, Hattori, Noboru, Kohno, Nobuoki, Itoh, Kyogo
Publicado 2017

Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial

por Noguchi, Masanori, Arai, Gaku, Egawa, Shin, Ohyama, Chikara, Naito, Seiji, Matsumoto, Kazumasa, Uemura, Hirotsugu, Nakagawa, Masayuki, Nasu, Yasutomo, Eto, Masatoshi, Suekane, Shigetaka, Sasada, Tetsuro, Shichijo, Shigeki, Yamada, Akira, Kakuma, Tatsuyuki, Itoh, Kyogo
Publicado 2020

Discontinuation of pembrolizumab for advanced urothelial carcinoma without disease progression: Nationwide cohort study

por Ito, Katsuhiro, Kita, Yuki, Yokomizo, Akira, Miki, Jun, Yoshio, Yuko, Matsumoto, Hiroaki, Segawa, Takehiko, Karashima, Takashi, Nishiyama, Naotaka, Imai, Kazuto, Suekane, Shigetaka, Nagasawa, Seiji, Higashi, Shin, Nishiyama, Hiroyuki, Kitamura, Hiroshi, Kobayashi, Takashi
Publicado 2022

Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patients

por Suekane, Shigetaka, Yutani, Shigeru, Yamada, Akira, Sasada, Tetsuro, Matsueda, Satoko, Takamori, Shinzo, Toh, Uhi, Kawano, Kouichiro, Yoshiyama, Koichi, Sakamoto, Shinjiro, Sugawara, Shunichi, Komatsu, Nobukazu, Yamada, Teppei, Naito, Masayasu, Terasaki, Mizuhiko, Mine, Takashi, Itoh, Kyogo, Shichijo, Shigeki, Noguchi, Masanori
Publicado 2020

Radiotherapy plus androgen deprivation therapy for prostate‐specific antigen persistence in lymph node–positive prostate cancer

por Shiota, Masaki, Takamatsu, Dai, Kimura, Takahiro, Tashiro, Kojiro, Matsui, Yoshiyuki, Tomida, Ryotaro, Saito, Ryoichi, Tsutsumi, Masakazu, Yokomizo, Akira, Yamamoto, Yoshiyuki, Edamura, Kohei, Miyake, Makito, Morizane, Shuichi, Yoshino, Takayuki, Matsukawa, Akihiro, Narita, Shintaro, Matsumoto, Ryuji, Kasahara, Takashi, Hashimoto, Kohei, Matsumoto, Hiroaki, Kato, Masashi, Akamatsu, Shusuke, Joraku, Akira, Kato, Manabu, Yamaguchi, Takahiro, Saito, Toshihiro, Kaneko, Tomoyuki, Takahashi, Atsushi, Kato, Takuma, Sakamoto, Shinichi, Enokida, Hideki, Kanno, Hidenori, Terada, Naoki, Suekane, Shigetaka, Nishiyama, Naotaka, Eto, Masatoshi, Kitamura, Hiroshi
Publicado 2022